{
  "title": "Surveillance: Vaccine Optimism With Hornbach",
  "itunes:title": "Surveillance: Vaccine Optimism With Hornbach",
  "description": "<p>Matthew Hornbach, Morgan Stanley Global Head of Macro Strategy, says a vaccine has the power to really drive risk assets higher, credit spreads tighter, the equity market higher, emerging-market currencies stronger. Mercedes Carnethon, Northwestern University Professor of Preventive Medicine, discusses the possible effectiveness of the vaccine being developed by Pfizer and BioNTech. Jaret Seiberg, Cowen Senior Policy Analyst, says the U.S. election presented a clear victory for the modern side of the Democratic Party. Daniel Alpert, Westwood Capital Managing Partner, says investors should keep an eye on aggregate demand.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "content:encoded": "<p>Matthew Hornbach, Morgan Stanley Global Head of Macro Strategy, says a vaccine has the power to really drive risk assets higher, credit spreads tighter, the equity market higher, emerging-market currencies stronger. Mercedes Carnethon, Northwestern University Professor of Preventive Medicine, discusses the possible effectiveness of the vaccine being developed by Pfizer and BioNTech. Jaret Seiberg, Cowen Senior Policy Analyst, says the U.S. election presented a clear victory for the modern side of the Democratic Party. Daniel Alpert, Westwood Capital Managing Partner, says investors should keep an eye on aggregate demand.</p><p>See <a href=\"https://omnystudio.com/listener\">omnystudio.com/listener</a> for privacy information.</p>",
  "itunes:episodeType": "full",
  "itunes:author": "Bloomberg",
  "itunes:image": "",
  "media:content": [
    {
      "media:player": ""
    },
    ""
  ],
  "guid": "d6668c46-1d22-11eb-804c-8bb8b3a1dcdb",
  "omny:clipId": "a66d35f8-2eb9-4cef-a6e9-ae2700614d25",
  "pubDate": "Mon, 09 Nov 2020 16:20:55 +0000",
  "itunes:duration": 1697,
  "enclosure": "",
  "link": "https://omny.fm/shows/bloomberg-surveillance/surveillance-vaccine-optimism-with-hornbach"
}